Habitual Coffee Consumption Does Not Correlate with Blood Pressure, Inflammation and Endothelial Dysfunction but Partially Correlates with Oxidative Stress

Erizal Sugiono, Mansyur Arif, Anwar Santoso

Abstract


BACKGROUND: Coffee is the most widely consumed beverage in the world and has been known to have effects on cardiovascular system. Many researchers have examined the effects of coffee consumption on blood pressure (BP) and risk of cardiovascular disease (CVD), but their results were inconsistent and still remain a subject of controversy. Oxidative stress, inflammation, and endothelial dysfunction have been known as risk factors of hypertension and CVD. Those factors are also known to be affected by coffee consumption. The aim of this study was to examine the relationship between the effects of habitual coffee consumption on BP and to examine the role of oxidative stress (F2 isoprostane), inflammation (high sensitive C-reactive protein (hsCRP)) and endothelial dysfunction (asymmetric dimethylarginine (ADMA)).

METHODS: This was a cross-sectional study in which 47 healthy, non-smoking men aged 30-60 years with varying coffee-drinking habits were enrolled. BP and blood/urine analysis of biomarkers were measured in the morning before activity. Coffee consumption was assessed using a questionnaire. The differences among variables were analyzed using ANOVA and the correlations between variables were analyzed using Kendall’s Tau correlation analysis.

RESULTS: Habitual coffee consumption did not correlate with systolic/diastolic BP (r=-0.02; p=0.856 and r=0.15; p=0.230, respectively). Concentrations of ADMA and hsCRP were also not correlated with coffee consumption (r=0.03; p=0.764 and r=0.04; p=0.701, respectively). Coffee consumption only showed significant correlation with F2 isoprostane (r=0.34; p=0.004).

CONCLUSION: BP was not affected by coffee consumption although coffee consumption has a significant correlation with F2 isoprostane. These findings suggest that correlation between coffee consumption and BP might be explained by other factors that were not included in this study.

KEYWORDS: coffee, caffeine, cardiovascular disease, blood pressure, oxidative stress, inflammation, endothelial dysfunction


Full Text:

PDF

References


James JE. Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously. Psychosom Med. 2004; 66: 63-71, CrossRef.

Van’t Hoff W. Caffeine in pregnancy. Lancet. 1982; 319: 1020, CrossRef.

Cornelis MC, El-Sohemy A. Coffee, caffeine, and coronary heart disease. Curr Opin Lipidol. 2007; 18: 13-9, CrossRef.

Ricketts ML, Boekschoten MV, Kreeft AJ, Hooiveld GJEJ, Moes CJA, Müler M, et al. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol Endocrinol. 2007; 21: 1603-16, CrossRef.

Svilaas A, Sakhi AK, Andersen LF, Svilaas T, Strom EC, Jacobs Jr DR, et al. Intakes of antioxidants in coffee, wine, and vegetables are correlated with plasma carotenoids in humans. J Nutr. 2004; 134: 562-67, PMID.

Olthof MR, Hollman PC, Katan MB. Chlorogenic acid and caffeic acid are absorbed in humans. J Nutr. 2001; 131: 66-71, PMID.

Brown RD, Thorén P, Steege A, Mrowka R, Sällström J, Skøtt O, et al. Influence of the adenosine A1 receptor on blood pressure regulation and renin release. Am J Physiol Regul Integr Comp Physiol. 2006; 290: R1324-9, CrossRef.

Varani K, Portaluppi F, Gessi S, Merighi S, Ongini E, Belardinelli L, et al. Dose and time effects of caffeine intake on human platelet adenosine A2A receptor: Functional and biochemical aspects. Circulation. 2000; 102: 285-9, CrossRef.

Hamer M. Coffee and health: Explaining conflicting results in hypertension. J Hum Hypertens. 2006; 20: 909-12, CrossRef.

Noordzij M, Uiterwaal CS, Arends LR, Kok FJ, Grobbee DE, Geleijnse JM. Blood pressure response to chronic intake of coffee and caffeine: A meta-analysis of randomized controlled trials. J Hypertens. 2005; 23: 921-8, CrossRef.

Winkelmayer WC, Stampfer MJ, Willett WC, Curhan GC. Habitual caffeine intake and the risk of hypertension in woman. JAMA. 2005; 294: 2330-5, CrossRef.

Lopez-Garcia E, Dam van RM, Willett WC, Rimm EB, Manson JE, Stampfer MJ, et al. Coffee consumption and coronary heart disease in men and women: A prospective cohort study. Circulation. 2006; 113: 2045-53, CrossRef.

Klag MJ, Wang NY, Meoni LA, Brancati FL, Cooper LA, Liang KY, et al. Coffee intake and risk of hypertension, the John Hopkins precursor study. Arch Intern Med. 2002; 162: 657-62, CrossRef.

Lovallo WR, Wilson MF, Vincent AS, Sung BH, McKey BS, Whitsett TL. Blood pressure response to caffeine shows incomplete tolerance after short-term regular consumption. Hypertension. 2004; 43: 760-5, CrossRef.

Hartley TR, Sung BH, Pincomb GA, Whitsett TL, Wilson MF, Lovallo WR. Hypertension risk status and effect of caffeine on blood pressure. Hypertension. 2000; 36: 137-41, CrossRef.

Fredholm BB, Battig K, Holmen J, Nehlig A, Zvartau EE. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol Rev. 1999; 51: 83-133, PMID.

Pesce AJ, Rashkin M, Kotagal U. Standard of laboratory practice: theophylline and caffeine monitoring. National Academy of Clinical Biochemistry. Clin Chem. 1988; 44(5): 1126-8, PMID.

Myers MG, Champagne CM. Nutritional effects on blood pressure. Curr Opin Lipidol. 2007; 18: 20-4, CrossRef.

Happonen P, Voutilainen S, Salonen JT. Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men. J Nutr. 2004; 134: 2381-6, PMID.

Mesas AE, Leon-Muñoz LM, Rodriguez-Artalejo F, Lopez-Garcia E. The effect of coffee on blood pressure and cardiovascular disease in hypertensive individuals: A systematic review and meta-analysis. Am J Clin Nutr. 2011; 94: 1113-26, CrossRef.

Zampelas A, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C. Associations between coffee consumption and inflammatory markers in healthy persons: The ATTICA study. Am J Clin Nutr. 2004; 80: 862-7, PMID.

Papamichael CM, Aznaouridis KA, Karatzis EN, Karatzi KN, Stamatelopoulos KS, Vamvakou G, et al. Effect of coffee on endothelial function in healthy subjects: The role of caffeine. Clin Sci. 2005; 109: 55-60, CrossRef.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-13, CrossRef.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42: 1206-52, CrossRef.

Andersen LF, Jacobs DR, Carlsen MH, Blomhoff R. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular disease in the Iowa woman’s health study. Am J Clin Nutr. 2006; 83: 1039-46, PMID.

Hamer M, Williams ED, Vuononvirta R, Gibson EL, Steptoe A. Association between coffee consumption and markers of inflammation and cardiovascular function during mental stress. J Hypertens. 2006; 24: 2191-7, CrossRef.

Panagiotakos DB, Pitsavos C, Chrysohoou C, Kokkinos P, Toutouzas P, Stefanadis C. The J-shaped effect of coffee consumption on the risk of developing acute coronary syndromes: The CARDIO2000 case control study. J Nutr. 2003; 133: 3228-32, PMID.

Silletta MG, Marfisi RM, Levantesi G, Boccanelli A, Chieffo C, Franzosi MG, et al. Coffee consumption and risk of cardiovascular events after acute myocardial infarction-result from the GISSI prevenzione trial. Circulation. 2007; 116: 2944-51, CrossRef.

Uiterwaal CS, Verschuren WM, Bueno-de-Mesquita HB, Ocké M, Geleijnse JM, Boshuizen HC, et al. Coffee intake and incidence of hypertension. Am J Clin Nutr. 2007; 85: 718-23, PMID.

Mayorov DN. Does coffee reinforce the vascular inflammatory response to mental stress? J Hypertens. 2006; 24: 2149-51, CrossRef.

Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H. Coffee, CYP1A2 genotype, and risk of myocardial infarction. JAMA. 2006; 295: 1135-41, CrossRef.




DOI: https://doi.org/10.18585/inabj.v5i1.51

Indexed by:

                 

                  

               

     

 

The Prodia Education and Research Institute